Cencora Inc. (COR) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Cencora Inc., updated every trading day.
Health Care · Other Pharmaceuticals
Price
$324.35
−0.31% today
Market cap
$62.1B
Overall quality
50/100
Kronos AI 30-day
−5.6%
2 of 8 simulated paths end higher
Cencora Inc. (COR) is a Health Care company in Other Pharmaceuticals, worth $62.1B. It trades at $324.35, down 0.31% today, at 23.6 times earnings. Its overall quality score is 50 out of 100, ranked against the whole US market. 13 analysts' average target of $370.69 implies +14.3% from today's price. Kronos AI's 30-day forecast is −5.6% (2 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $370.69 |
| Low – high | $330.00 – $400.00 |
| Analysts | 13 |
| Upside to average | +14.3% |
Kronos AI 30-day forecast
| Expected close | $307.24 (−5.6%) |
| Likely range | −11.1% … +0.8% |
| As of | 2026-10-27 |
2 of 8 simulated paths end higher.
Quality scores
| Profitability | 62 |
| Solvency | 33 |
| Growth | 54 |
| Overall | 50 |
| P/E | 23.6 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Other Pharmaceuticals
For information only, not investment advice. Prices updated: 2026-10-29.